(4-(6-((4-(benzo[d]thiazol-5-yl)-5-fluoropyrimidin-2-yl)amino)nicotinoyl)piperazin-1-yl)(cyclopropyl)methanone

ID: ALA5277043

Max Phase: Preclinical

Molecular Formula: C25H22FN7O2S

Molecular Weight: 503.56

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(Nc2ncc(F)c(-c3ccc4scnc4c3)n2)nc1)N1CCN(C(=O)C2CC2)CC1

Standard InChI:  InChI=1S/C25H22FN7O2S/c26-18-13-28-25(31-22(18)16-3-5-20-19(11-16)29-14-36-20)30-21-6-4-17(12-27-21)24(35)33-9-7-32(8-10-33)23(34)15-1-2-15/h3-6,11-15H,1-2,7-10H2,(H,27,28,30,31)

Standard InChI Key:  JFRWDFXEEIFVJB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
    2.8598    2.6721    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8598    1.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5736    1.4336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5736    0.6086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8572    0.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8572   -0.6278    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1407   -1.0368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1407   -1.8605    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4211   -2.2689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7097   -1.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0076   -2.2608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7194   -1.8437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4391   -2.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1448   -1.8315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1448   -1.0045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8549   -0.5845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8549    0.2403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2639    0.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4123    0.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5736   -0.9897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4250   -0.5971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7194   -1.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0076   -3.0858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7097   -1.0296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4294   -0.6212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1446    0.6108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1446    1.4358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4301    1.8483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4301    2.6732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7156    3.0858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0011    2.6732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7830    2.9283    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2681    2.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7830    1.5932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0011    1.8481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7156    1.4356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 17  1  0
 16 20  2  0
 15 21  1  0
 21 22  1  0
 22 12  1  0
 11 23  2  0
 10 24  1  0
 24 25  2  0
 25  7  1  0
  5 26  1  0
 26 27  2  0
 27  2  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  1  0
 35 36  2  0
 36 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5277043

    ---

Associated Targets(Human)

DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 503.56Molecular Weight (Monoisotopic): 503.1540AlogP: 3.73#Rotatable Bonds: 5
Polar Surface Area: 104.21Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.62CX Basic pKa: 2.14CX LogP: 3.01CX LogD: 3.01
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.44Np Likeness Score: -1.81

References

1. Yuan K, Shen H, Zheng M, Xia F, Li Q, Chen W, Ji M, Yang H, Zhuang X, Cai Z, Min W, Wang X, Xiao Y, Yang P..  (2023)  Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer.,  66  (6): [PMID:36800260] [10.1021/acs.jmedchem.3c00106]

Source